跳到正文
← 返回论文列表与筛选
阅读说明

本页整理公开书目信息,不生成学术质量评分。AI 解读根据题名及所注明的摘要或原文片段生成,未完成全文核验,可能有误;具体假设、证明与结论请核对原文。摘要保留来源文本,未经模型改写。

DOI 首次登记不等于接收或发表日期。部分更正、评论等条目没有独立摘要;缺少可靠材料时保留待补状态。

引用量采用 OpenAlex 单条关联记录,不合计多个记录;关联记录可能包含正式发表版本,不等于此版本单独引用。缺失不视为零,引用指标不代表论文质量。

关注作者按书目中的完整姓名匹配,同名和姓名变体需人工辨别。相关论文先按共享细分方向和具体方法排列,再参考通用方法与发表日期。

分类依据与纠错

AI 根据所提供的论文材料归类:摘要明确研究连续分位数区间上的删失分位数回归及协变量关联异质性。

反馈分类问题

正在核对关联版本…

代码、数据与补充材料

正在核对对应版本的资源…

关注这篇论文的作者
Zhe Fei
Qi Zheng
Hyokyoung G. Hong
Yi Li

高维删失分位数回归的统计推断

研究问题
面对高维生物标志物和删失生存结局,如何在连续分位数区间上推断所有预测变量的关联,并量化这些关联的异质性?
方法与思路
作者在全局删失分位数回归框架中,结合多次样本分割、变量选择及一系列低维模型估计,构造面向所有预测变量的估计量。
材料陈述的贡献
摘要称估计量在正则条件下具有一致性和按分位数索引的高斯过程极限,并用模拟与肺癌队列数据展示不确定性量化。
阅读关注点
应核对删失与变量选择条件、多次分割结果的合并方式,以及高斯过程极限如何用于区间内推断和多变量不确定性量化。
阅读边界
仅依据 OpenAlex 索引摘要,稿件版本未注明;正则条件与具体置信程序未展开,协变量关联不能直接解释为因果效应,亦不能推断刊本变化。

原文摘要

With the availability of high dimensional genetic biomarkers, it is of interest to identify heterogeneous effects of these predictors on patients' survival, along with proper statistical inference. Censored quantile regression has emerged as a powerful tool for detecting heterogeneous effects of covariates on survival outcomes. To our knowledge, there is little work available to draw inference on the effects of high dimensional predictors for censored quantile regression. This paper proposes a novel procedure to draw inference on all predictors within the framework of global censored quantile regression, which investigates covariate-response associations over an interval of quantile levels, instead of a few discrete values. The proposed estimator combines a sequence of low dimensional model estimates that are based on multi-sample splittings and variable selection. We show that, under some regularity conditions, the estimator is consistent and asymptotically follows a Gaussian process indexed by the quantile level. Simulation studies indicate that our procedure can properly quantify the uncertainty of the estimates in high dimensional settings. We apply our method to analyze the heterogeneous effects of SNPs residing in lung cancer pathways on patients' survival, using the Boston Lung Cancer Survivor Cohort, a cancer epidemiology study on the molecular mechanism of lung cancer.

笔记与分组
相关领域论文